Chaim Gilon
27Patents
9h-index
33Co-inventors
75Inventor score
Filing activity: Apr 16, 1991 → Mar 12, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5217999A | Styryl compounds which inhibit EGF receptor protein tyrosine kinase | Chemistry; Metallurgy | 183 | Expired |
| US5302606A | Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase | Chemistry; Metallurgy | 176 | Expired |
| US5874529A | Conformationally constrained backbone cyclized peptide analogs | Emerging Cross-Sectional Technologies | 73 | Expired |
| US7084244B2 | Conformationally constrained backbone cyclized peptide analogs | Emerging Cross-Sectional Technologies | 57 | Expired |
| US5196446A | Certain indole compounds which inhibit EGF receptor tyrosine kinase | Chemistry; Metallurgy | 48 | Expired |
| US5770687A | Comformationally constrained backbone cyclized somatostatin analogs | Emerging Cross-Sectional Technologies | 29 | Expired |
| US5811392A | Conformationally constrained backbone cyclized peptide analogs | Emerging Cross-Sectional Technologies | 15 | Expired |
| US5656655A | Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinase | Chemistry; Metallurgy | 12 | Expired |
| US5723575A | Process for the preparation of backbone cyclic peptides | Emerging Cross-Sectional Technologies | 10 | Expired |
| USRE38761E1 | Styryl compounds which inhibit EGF receptor protein tyrosine kinase | General | 9 | Expired |
| US5883293A | Conformationally constrained backbone cyclized peptide analogs | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6117974A | Libraries of backbone-cyclized peptidomimetics | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6265375A | Conformationally constrained backbone cyclized peptide analogs | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5677329A | Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase | Chemistry; Metallurgy | 4 | Expired |
| US6407059B1 | Conformationally constrained backbone cyclized peptide analogs | Emerging Cross-Sectional Technologies | 3 | Expired |
| US8658603B2 | Compositions and methods for inducing an immune response | Human Necessities | 2 | Active |
| US5990277A | Semipeptoid farnesyl protein transferase inhibitors and analogs thereof | Human Necessities | 1 | Expired |
| US10155790B2 | Antagonists of neurokinin B in fish reproduction | Emerging Cross-Sectional Technologies | 1 | Active |
| US10793614B2 | Antagonists of fish reproduction | Human Necessities | 0 | Active |
| US11261215B2 | Somatostatin prodrugs | Human Necessities | 0 | Active |
| US10662225B2 | Backbone cyclized inhibitory peptides of myeloid differentiation factor 88 (MyD88) | Human Necessities | 0 | Active |
| US6664368B1 | Inhibition of nuclear import by backbone cyclic peptide analogs | Chemistry; Metallurgy | 0 | Expired |
| US11267846B2 | High shear solid phase synthesis | Performing Operations; Transporting | 0 | Active |
| US8198218B2 | Heterocyclic compounds, combinatorial libraries thereof and methods of selecting drug leads | Chemistry; Metallurgy | 0 | Active |
| US11965041B2 | N-methylated cyclic peptides and their prodrugs | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.